Infectivity of porcine circovirus type 2 DNA in semen from experimentally-infected boars by Madson, D.M. et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Infectivity of porcine circovirus type 2 DNA in semen from
experimentally-infected boars
Citation for published version:
Madson, DM, Pal, N, Halbur, PG, Opriessnig, T, Ramamoorthy, S, Meng, X-J & Kuster, C 2009, 'Infectivity
of porcine circovirus type 2 DNA in semen from experimentally-infected boars' Veterinary Research, vol. 40,
no. 1, 10. DOI: 10.1051/vetres:2008048
Digital Object Identifier (DOI):
10.1051/vetres:2008048
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Veterinary Research
Publisher Rights Statement:
Copyright 2008 INRA, EDP Sciences.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 05. Apr. 2019
Vet. Res. (2009) 40:10 www.vetres.org
DOI: 10.1051/vetres:2008048
C© INRA, EDP Sciences, 2008 Original article
Infectivity of porcine circovirus type 2 DNA in semen
from experimentally-infected boars
Darin M. Madson1, Sheela Ramamoorthy2, Chris Kuster3, Narinder Pal1,
Xiang-Jin Meng2, Patrick G. Halbur1, Tanja Opriessnig1*
1 Department of Veterinary Diagnostic and Production Animal Medicine, College of Veterinary Medicine,
Iowa State University, Ames, Iowa, USA
2 Department of Biomedical Sciences and Pathobiology, Center for Molecular Medicine and Infectious Diseases,
College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA
3 Kuster Research and Consulting, 22509 East 1680th Street, Geneseo, Illinois, 61254, USA
(Received 16 July 2008; accepted 29 October 2008)
Abstract – Porcine circovirus type 2 (PCV2) is an economically important pathogen. It has been
demonstrated that PCV2 DNA can be detected in boar semen by PCR; however, the biological
relevance of this is unknown. The objectives of this study were to determine if semen positive
for PCV2 DNA is infectious (1) in a swine bioassay, or (2) when used for artificial insemination.
For the first objective, 4-week-old pigs were inoculated intraperitoneally with PCV2 DNA-negative
(bioassay-control; n = 3), PCV2a DNA-positive (bioassay-PCV2a; n = 3), or PCV2b DNA-positive
(bioassay-PCV2b; n = 3) raw semen, or PCV2 live virus (bioassay-positive; n = 3), respectively. Pigs
inoculated with PCV2 DNA-positive semen and PCV2 live virus became viremic and developed
anti-PCV2 antibodies indicating that the PCV2 DNA present in semen was infectious. For the second
objective, three Landrace gilts were inseminated with PCV2 DNA-negative semen (gilts-controls) from
experimentally-infected boars, and six gilts were artificially inseminated with semen positive for PCV2a
DNA (gilts-PCV2a; n = 3) or PCV2b DNA (gilts-PCV2b; n = 3). Serum samples collected from the
gilts in all groups remained negative for anti-PCV2 antibodies for the duration of the experiment.
In addition, fetal serum samples from all 105-day-gestation fetuses were negative for anti-PCV2
antibodies or PCV2 DNA. Under the conditions of this study, PCV2 DNA-positive semen was not
infectious when used to artificially inseminate gilts; however, it was demonstrated to be infectious
in a swine bioassay model and therefore is a potential means of PCV2 transmission amongst swine
herds.
artificial insemination / bioassay / boar / PCV2 / semen
1. INTRODUCTION
Porcine circovirus type 2 (PCV2) is asso-
ciated with many disease entities among
growing and mature swine, including repro-
ductive failure in pregnant females [31]. In
breeding herds, natural infection of pregnant
animals with PCV2 has been associated with
reproductive failure manifested as abortions,
mummification of fetuses and stillbirths with
* Corresponding author: tanjaopr@iastate.edu
identification of PCV2 antigen associated with
lesions in fetal tissues [17, 26, 57].
Vertical transmission of PCV2 can occur
due to viremia of the dam leading to
transplacental infection of in utero fetuses
[17, 26, 34, 57]. The virus is capable of
replicating in fetal tissues [13, 42, 59] and
has a tropism for mitotically active cells
within tissues which change depending on
fetal age [43].
Currently little is known about the role of
PCV2 in semen and the transmission of PCV2
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to dams or fetuses. Artificial insemination has
become standard practice by most large pro-
duction systems in North America in recent
decades which followed the trend occurring
in Europe [9]. In 2001, it was estimated that
nearly 60% of the swine herds in North Amer-
ica were practicing artificial insemination [50]
as compared with Europe where estimates
approach 90% or greater [9, 19, 21]. The
main advantage of artificial insemination is
genetic improvement [37]. However, semen
may be a source for virus introduction and
rapid spread [11], and monitoring boar centers
particularly for porcine reproductive and
respiratory syndrome virus (PRRSV) is a
common practice to prevent disease transmis-
sion [41]. Currently, monitoring for PCV2 is
not routinely done at Veterinary Diagnostic
Laboratories.
Detection of PCV2 DNA in semen has
been accomplished by using nested PCR
(nPCR) techniques [14, 18, 23], quantita-
tive real-time PCR (qPCR) [33], and virus
isolation [14]. PCV2 DNA was found to
be shed intermittently or continuously in
experimentally challenged boars [18, 20]. The
amount of PCV2 DNA in semen is generally
in low quantities and serum viremia usually
precedes detection in semen [18, 20]. In
addition, shedding of PCV2 DNA in semen
has been reported up to 27.3 months in nat-
urally infected boars [23]. All associated sex
glands contain PCV2 DNA after infection [20]
and PCV2 antigen can also be detected in
interstitial macrophages and fibroblast-like
cells in sex glands of affected boars [29].
To date, it is unclear whether the PCV2
present in semen is infectious and if artificial
insemination with PCV2 DNA-positive semen
can cause PCV2 transmission or reproductive
failure. To assess the infectivity of PCV2 DNA
in semen and its role in transmission of PCV2,
two studies were designed: The first objective
was to determine if PCV2 DNA-positive
semen is infectious in a swine bioassay
model. The second objective was to determine
whether PCV2 DNA-positive semen used for
artificial insemination is infectious to PCV2
naïve gilts, can be transmitted to offspring, or
induce reproductive failure.
2. MATERIALS AND METHODS
2.1. Animals
2.1.1. Swine bioassay study
Twelve four-week-old mixed breed pigs were
purchased from a commercial farm negative for
antibodies to PCV2, PRRSV, and swine influenza
virus (SIV).
2.1.2. Artificial insemination study
Nine three-week-old purebred Landrace gilts
were purchased from a farm negative for antibodies
to PRRSV and SIV and positive for antibodies to
PCV2.
2.2. Semen
Raw semen negative for PCV2 DNA, raw semen
positive for PCV2a DNA, and raw semen positive
for PCV2b DNA used in this study was collected
from a PCV2 experimental trial in which boars
were intranasally and intramuscularly inoculated
with PCV2a and PCV2b, respectively [20, 33].
The PCV2a isolate (ISU-40895) and the PCV2b
isolate (NC-16845) were originally obtained from
finishing pigs with microscopic lesions consistent
with PCVAD and associated with PCV2 antigen.
Both isolates have previously been shown to
cause disease in experimentally-infected pigs [32].
The raw semen samples tested negative for the
presence of porcine circovirus type 1 (PCV1) DNA,
porcine parvovirus (PPV) DNA, or PRRSV RNA
by PCR [3, 15]. Aliquots of fresh raw semen were
saved and placed into sterile 5 mL polystyrene
round-bottom tubes (Falcon®, BD Biosciences,
San Jose, CA, USA) and stored at –80 ◦C. The
remaining raw semen was extended at a 1:1 dilution
with a commercially available semen extender
(TriXcell, IMV International, Minneapolis, MN,
USA), which was warmed to match semen
temperature, and the extended semen was then
cooled to approximately 17 ◦C. A portion of each
semen sample was further diluted with semen
extender to approximately 5 billion sperm per
80 mL insemination dose. The extended semen was
stored at 17 ◦C for up to 96 h and rotated twice daily.
2.3. Animals, housing, experimental design,
and inoculation
Both experimental protocols were approved by
the Iowa State University Institutional Animal Care
and Use Committee.
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Table I. Swine bioassay study: Experimental design.
Group na Inoculum Amount Dose Route
Bioassay-control 3 PCV2 DNA-negative semen 7 mL – IP∗
Bioassay-PCV2a 3 PCV2a DNA-positive semen 7 mL 105.6b IP
Bioassay-PCV2b 3 PCV2b DNA-positive semen 7 mL 105.8b IP
Bioassay-positive 3 PCV2 live virus 3 mL 104.5c IP
a Number of pigs in each group;
b PCV2 genomic copy numbers/mL of raw semen;
c Tissue culture infectious dose (TCID50);
∗ Intraperitoneally.
2.3.1. Swine bioassay study
The pigs were randomly divided into 4 groups
(Tab. I) and each group was housed in a separate
room on arrival at the isolation facility. Each room
was equipped with an ante-room where personnel
protective equipment (face masks, boots, gloves,
and disposable covers) were supplied for room
entrance by animal care takers, and each room was
ventilated separately. Animals were contained in
a 1.5 × 2.5 m pen supplied with a nipple drinker
and a self feeder. Animals were fed ad libidum
a balanced, pelleted, complete feed ration free of
animal proteins and antibiotics (Nature’s Made,
Heartland Coop, IA, USA).
Inoculation was done intraperitoneally for all
groups using an aseptic technique and a 24 gauge,
1/2 inch hypodermic needle as described [54]. The
bioassay-control group received 7 mL of PCV2
DNA-negative raw semen, the bioassay-PCV2a
group received 7 mL PCV2a DNA-positive raw
semen, and the bioassay-PCV2b group received
7 mL PCV2b DNA-positive raw semen. The
number of PCV2 genomic copy numbers/mL of raw
semen was 105.6 and 105.8 for PCV2a and PCV2b,
respectively. The PCV2a and PCV2b isolates
shared 95.7% nucleotide sequence identity. The
bioassay-positive group received 3 mL of PCV2a
live virus (ISU-40895) generated by transfection of
PK-15 cells with the PCV2a ISU-40895 infectious
DNA clone [8] at a dose of 104.5 TCID50 combined
with 4 mL of sterile saline.
Serum samples were collected prior to inoc-
ulation (Day 0 post inoculation; DPI 0) and
weekly thereafter. On DPI 49, all pigs were
humanely euthanized by lethal overdose of intra-
venous (auricular vein) pentobarbital (Fatal-Plus®,
Vortech Phamaceutical, LTD, Dearborn, MI, USA).
At necropsy, gross lesions were assessed on each
pig and tissues from all major organ systems
were collected for microscopic examination and
immunohistochemistry (IHC).
2.3.2. Artificial insemination study
The gilts were randomly divided into 3
treatment groups (Tab. II) and isolation rooms
at 8 months of age. The general room set-up
was similar to that described for the bioassay
pigs. The gilts were housed in a 2 × 4 m pen
supplied with a nipple drinker. Animals were
fed daily approximately 2.5 kg of a balanced
ground corn-soy based complete feed ration
free of animal proteins and antibiotics (Nature’s
Made). Prior to artificial insemination, gilts were
Table II. Artificial insemination study: Experimental design. Each sow was inseminated three times (dose
1, 2, 3) 24 h apart during estrus.
Artificial inseminationbGroup na Inoculum Raw semenb Route
1st dose 2nd and 3rd dose
Gilts-Control 3 PCV2-DNA-negative semen – – – AI∗
Gilts-PCV2a 3 PCV2a-DNA-positive semen 105.6 105.3 104.4 AI
Gilts-PCV2b 3 PCV2b-DNA-positive semen 105.8 105.5 104.6 AI
a Number of pigs in each group;
b PCV2 genomic copy numbers/mL;
∗ Artificial insemination.
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individually synchronized for estrus detection
for 17 consecutive days using a commercially
available liquid altrenogest (Matrix®, Intervet
Inc., Millsboro, DE, USA), that was added to
the daily feeding at the recommended dosage
(15 mg). Twenty-four hours after termination of
the treatment, each animal received a 5 mL
intramuscular injection of gonadotropin (P.G.
600®, Intervet Inc.) and was then bred by artificial
insemination upon estrus detection. Each gilt was
artificially inseminated three times during standing
estrus with 24 h between each insemination to
ensure coverage of ovulation. Initially, 80 mL of 1:1
extended raw semen (40 mL raw semen and 40 mL
extender) (collected on the same day) was used.
For second and third artificial insemination matings,
semen extended to approximately 5 billion sperm
per 80 mL dose was used (5 mL of raw semen to
75 mL extender).
To evaluate a potential negative effect of the
semen extender used on infectivity of the PCV2,
an equal amount of extender was added to PCV2
live virus in a 1:1 dilution. In addition and as a
control, PCV2 live virus was diluted with minimum
essential medium (MEM) in a dilution of 1:1. The
PCV2 titer was estimated by immunofluorescence
assay (IFA) with PCV2 a specific antibody as
described [8] at 0, 8, 24, 48, and 96 h post dilution.
Serum samples from all gilts were collected
prior to insemination and weekly thereafter. At
approximately 5 and 8 weeks post artificial
insemination, ultrasonography was used to confirm
pregnancy. Necropsy was performed at 105 days of
gestation and gilts were euthanized by intravenous
(auricular vein) overdose of pentobarbital. All
fetuses from were immediately extracted and fetal
serum was collected.
2.4. Serology
All weekly collected serum samples were
analyzed for presence of anti-PCV2 IgG antibodies
with an opening reading frame 2 (ORF2) based
PCV2 ELISA as previously described [25]. A serum
with a sample to positive ratio (s/p) equal or greater
than 0.2 was considered to be positive.
2.5. Quantitative real-time polymerase chain
reaction
Serum samples collected weekly from the
bioassay pigs and individual fetal serum samples
were tested for the presence and amount of
PCV2 DNA by quantitative real-time PCR as
described [27].
2.6. Sequencing
PCR products from the PCV2a or PCV2b
positive semen, the PCV2 inoculum, and serum
from one randomly selected pig at 49 DPI in each
of the bioassay groups (bioassay-PCV2a, bioassay-
PCV2b, and bioassay-positive) was sequenced and
compared to each other. A nested PCR was used
to amplify the entire ORF2 gene for sequencing
and subsequent sequence comparison as previously
described [30].
2.7. Necropsy
At necropsy, percentage of lungs affected
by lesions ranging from 0–100% [12] and
presence and degree of lymphadenopathy were
evaluated [27]. Both fresh tissues and tissues fixed
in 10% buffered formalin were collected. Tissues
included lung (all lobes), liver, spleen, kidney,
tonsil, ileum, colon, thymus, multiple lymph nodes
(tracheobronchial, mediastinal, mesenteric, iliac,
superficial inguinal) and myocardium. In addition,
uterus, ovary and placenta were collected from the
breeding animals.
2.8. Microscopic evaluation
The formalin fixed tissue samples were routinely
processed and stained with hematoxylin and eosin
for microscopic evaluation. Lungs, lymph nodes,
and other lymphoid tissues (tonsil and spleen) were
scored for the presence and severity of PCV2-
associated lesions as previously described [28] by
a veterinary pathologist blinded to the treatment
group.
2.9. Immunohistochemistry
IHC staining for detection of PCV2-antigen
in formalin fixed, paraffin embedded tissue was
performed on selected lymphoid tissues (tracheo-
bronchial, mediastinal, mesenteric, iliac, superficial
inguinal, thymus, tonsil, spleen and Peyer’s patches)
collected from all bioassay pigs as described [51].
Additionally, sections of ovary, uterus, and lym-
phoid tissue (tonsil and iliac lymph node) from all
gilts were tested by IHC for presence of PCV2
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Table III. Swine bioassay study: Incidence (number of pigs affected/number of pigs per group) of PCV2
DNA in serum (Serum PCR) and anti-PCV2 antibodies in serum (ELISA) by group at different days post
inoculation (DPI).
DPIGroup Sample
0 7 14 21 28 35 42 49
Bioassay-control Serum PCR 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
ELISA∗ 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
Bioassay-PCV2a Serum PCR 0/3 0/3 0/3 1/3 2/3 3/3 3/3 3/3
ELISA 0/3 0/3 0/3 0/3 1/3 1/3 2/3 3/3
Bioassay-PCV2b Serum PCR 0/3 0/3 0/3 2/3 2/3 3/3 3/3 3/3
ELISA 0/3 0/3 0/3 0/3 0/3 0/3 1/3 2/3
Bioassay-positive Serum PCR 0/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3
ELISA 0/3 0/3 3/3 3/3 3/3 3/3 3/3 3/3
∗ Pigs with a sample to positive ratio equal to or greater than 0.2 were considered positive.
antigen. The distribution and amount of PCV2
antigen in individually examined tissue sections
were scored ranging from 0 (no signal) to 3 (strong
signaling) as previously described [27].
3. RESULTS
3.1. Swine bioassay study
All DPI 0 serum samples were negative
for anti-PCV2 antibodies. Furthermore, the
bioassay-control pigs remained free of anti-
PCV2 IgG antibodies for the duration of the
study. One of three bioassay-PCV2a pigs had
detectable anti-PCV2 antibodies from DPI
28 onwards (Tab. III). The remaining two
bioassay-PCV2a pigs developed anti-PCV2
IgG antibodies by DPI 49. Two of three
bioassay-PCV2b pigs developed detectable
anti-PCV2 antibodies by DPI 49. All three of
the bioassay-positive pigs had detectable anti-
PCV2 IgG antibodies by DPI 14 and remained
positive for the duration of the trial.
PCV2 DNA was not detected in the weekly
collected bioassay-control serum samples for
the entire duration of the study nor from any
animal on DPI 0. PCV2 DNA was detected
in 1/3 bioassay-PCV2a pigs at DPI 21, 2/3
at DPI 28, and 3/3 at DPI 35 (Tab. III). All
pigs remained PCV2 viremic until termination
of the study. Two of three bioassay-PCV2b
pigs were positive for PCV2 DNA in serum
on DPI 21, and 3/3 pigs were PCV2 DNA
positive from DPI 35 until DPI 49. PCV2
DNA was detected in 3/3 serum samples from
bioassay-positive pigs on DPI 7, and all pigs
in this group remained viremic until DPI 49.
The sequence of the entire PCV2 ORF2 PCR
product collected in each treatment group on
DPI 49 was 99.9% similar to the original
inoculum.
Macroscopic lesions were not present in
the bioassay-control animals. Gross lesions in
the bioassay-PCV2a animals included mild-to-
moderate fibrinous peritonitis with mild lym-
phadenopathy (2/3), diffuse non-collapsing
lungs (1/3), and liver abscessation (1/3).
Bioassay-PCV2b gross lesions included fibri-
nous peritonitis (2/3) and mild lymphadenopa-
thy (1/3). All bioassay-positive animals had
diffuse non-collapsing lungs with mild-to-
moderate lymphadenopathy in 2/3 pigs.
Microscopically, 1/3 bioassay-control pigs
had mild multifocal lymphocytic inflamma-
tion expanding interstitial lung parenchyma.
The microscopic lesions in the bioassay-
PCV2a animals included moderate multifo-
cal lymphohistiocytic interstitial pneumonia
(3/3), mild multifocal lymphocytic interstitial
nephritis (1/3), and mild multifocal lympho-
cytic myocarditis (1/3). Microscopic lesions
in the bioassay-PCV2b pigs included mild-to-
moderate multifocal lymphohistiocytic inter-
stitial pneumonia in all pigs. Lesions in the
bioassay-positive group included mild to mod-
erate multifocal lymphohistiocytic interstitial
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Table IV. Effect of semen extender on the surviv-
ability of PCV2 in cell culture.
TimeSample
0 h 8 h 24 h 48 h 96 h
PCV2 + MEM∗ 104.5b 104.5 104.2 104.0 104.0
PCV2 + extendera 104.2 104.0 103.66 103.66 103.66
∗ PCV2 + MEM = 1:1 dilution of PCV2 live virus with
minimum essential medium;
a PCV2 + extender = 1:1 dilution of PCV2 live virus
with semen extender;
b Titer: expressed as 50% tissue infective dose per mL.
pneumonia (3/3), mild multifocal lymphocytic
interstitial nephritis (3/3) and mild lymphoid
depletion (1/3).
Low amounts of PCV2 antigen were
detected in lymph node sections of 2/3
bioassay-positive pigs. PCV2 antigen was not
detected in tissue sections of bioassay-control
pigs, bioassay-PCV2a pigs, or bioassay-
PCV2b pigs.
3.2. Artificial insemination study
In the extender-dilution-in-vivo-assay, the
starting titer of the PCV2 live virus diluted
with semen extender was determined to be
104.2 TCID50 per mL while the control virus
stock diluted with MEM had a titer of
104.5 TCID50 per mL (Tab. IV). The PCV2
titers slightly decreased over time, and the
final titer of PCV2 at 96 h post dilution was
104.0 TCID50 per mL and 103.66 TCID50 per
mL for the MEM diluted PCV2 and the
extender diluted PCV2, respectively (Tab. IV).
Three of 3 control gilts, 2/3 gilts-PCV2a,
and 3/3 gilts-PCV2b were confirmed pregnant
by ultrasonography at 35 and 56 days post
insemination. One animal in the gilt-PCV2a
group was breed on two consecutive estrus
cycles, but failed to become pregnant.
The total number of fetuses retrieved from
the gilts-control group was 25 with litter sizes
of 4, 7, and 14 fetuses (+1 mummy). The
total number of fetuses retrieved from the
gilts-PCV2a group was 16 with litters of 5
and 11 fetuses. The total number of fetuses
retrieved from gilts-PCV2b group was 40 with
litters of 9, 13, and 18 fetuses (+1 mummy).
Gross lesions were not observed in any of the
fetuses.
At the time of artificial insemination, all
gilts were negative for anti-PCV2 antibodies
as determined by ELISA (s/p ratio < 0.2).
None of the gilts developed anti-PCV2 IgG
antibodies during the 105 days post artificial
insemination. No gross lesions were observed
during necropsy, no microscopic lesions were
present in examined tissues, and IHC staining
of lymphoid tissue, ovary and uterus were
negative for PCV2 antigen in all gilts. All
79 fetal serum samples collected at 105 days
of gestation were negative for anti-PCV2
antibodies and for PCV2 DNA.
4. DISCUSSION
Transmission of PCV2 is presently not
well characterized, however, detection of
PCV2 DNA has been reported in secretions
and excretions including feces, urine, saliva,
ocular, nasal, colostrum and semen of infected
pigs [1, 16, 18, 47–49]. Rapid spread of
porcine circovirus associated disease
(PCVAD) across North America in recent
years has raised questions about the risk of
transmission of PCV2 in semen; however,
epidemiological investigation have not con-
firmed the relationship between PCV2 positive
semen and incidence of PCVAD [4, 38, 56].
Semen transmission of certain viruses
has been documented and is considered
economically important for the swine industry,
especially with the wide usage of artificial
insemination. A recent review summarized
viruses potentially shed in boar semen [11].
Currently, many North American boar stud
operations frequently test for the presence of
PRRSV by many methods for surveillance
purposes [36, 40], yet the presence of other
viruses associated with reproductive failure
including PCV2 are infrequently tested for,
although in one report 30% (13/43) of boars
tested where found to contain PCV2 DNA in
semen [23]. In other geographical locations,
PCV2 DNA was detected in 28 of 60 (47%)
and 26 of 98 (27%) semen samples obtained
from 30 and 49 Korean swine herds [14, 15],
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18% (86/472) of semen samples from Austrian
and German boars [44], and 22% (67/304)
of semen samples collected from 4 Brazilian
farms1. Other European countries have begun
to test boar semen for exportation for the
presence of PCV2 DNA to prevent the possible
spread of PCVAD2.
The significance of PCV2 in semen is
currently unknown and the purpose of this
study was to try to expand the knowledge
base on this topic. Due to the cytotoxicity
of semen [45] and the non-cytopathic effect
of PCV2 in cell culture, virus isolation tech-
niques can be misleading and unrewarding.
Thus, highly sensitive PCR methodologies are
currently used to determine if PCV2 is present
in semen. Polymerase chain reaction tech-
niques can detect the presence of PCV2 DNA
using small amounts of semen; however, pos-
itive PCR results do not necessarily correlate
with presence of infectious virus. Previously,
a swine bioassay model was developed to con-
firm the infectivity of PRRSV in semen [52].
In this study, a similar bioassay model was
used to test the infectivity of PCV2 DNA
present in semen.
The results of the PCV2 swine bioassay
confirm that PCV2a and PCV2b present in
semen are infectious as evidenced by the
detection of PCV2 viremia, seroconversion in
the recipients after inoculation, and micro-
scopic lesions compatible with PCV2 infec-
tion in growing pigs. In the experimental
PCV2 pig model using intranasal and/or intra-
muscular inoculations, anti-PCV2 antibodies
can be detected between 21–28 DPI [27]. The
delayed antibody response to PCV2 observed
in pigs intraperitoneally injected with PCV2
1 Ciacci-Zanella J.R., Zanella E.L., Locatelli M.L.,
Brambatti J.L., Simon N.L., Coldebella M.,
Detection of porcine circovirus 2 in semen collected
from naturally infected boar studs in Brazil, Proc.
5th International Symposium on Emerging and Re-
emerging Pig Disease, Karkow, 2007, p. 94.
2 Wallgren P., Blomqvist G., Thorén P., Elander J.,
Wallgren M., Incidence of PCV2 in semen collected
at Swedish boar stations, Proc. 20th International
Pig Veterinary Society Congress, Durban, 2008,
volume II, p. 62.
DNA-positive semen when compared to pigs
inoculated with PCV2 live virus may be dose
related. Additional considerations for delayed
response in antibody production may be due
to natural constituents present in semen [55]
or different antigens present competing for
an immunological response [6]. The peritoni-
tis present at necropsy may have been in
part induced by antigens present in the semen
or possibly by bacterial contamination during
intraperitoneal inoculation and this may have
contributed to some of the microscopic lesions
observed. Additionally, PCV2 antigen was
not detected in tissues from bioassay-PCV2a
pigs, or bioassay-PCV2b pigs in this study.
This result may due to the detection limits
of IHC because it has been previously esti-
mated that 108 PCV2 genomic copies are
needed in tissue sections for visualization of
IHC signaling [2].
Artificial insemination with semen contain-
ing PCV2 DNA did not result in dam or
fetal infection in this study even with the
initial insemination being diluted 1:1 with
extender. This may indicate that low exposure
to PCV2 in semen may be of lesser conse-
quence. In most field situations, a single semen
collection from a boar is typically diluted
into many insemination doses and commonly
mixed with semen samples from other boars
further decreasing the amount of PCV2 in
a dose of semen typically used for artificial
insemination. However, PCV2 has the abil-
ity to infect and replicate in different stages
(zona pellucida free morulae, early blastocysts
and hatched blastocysts) of in vivo produced
embryonic cells with increasing susceptibil-
ity of infection in the later stages [22]. It has
been shown that PCV2 with an approximate
diameter of 17 nm in size did not infect intact
zona pellucida morulae, although 20 nm diam-
eter fluorescent beads could pass through zona
pellucida pores. PCV2 is a difficult virus to
inactivate, thus PCV2 present in semen may
be a risk for infection [22]. PCV2 is associated
with the cell fraction portion of semen [33].
This may indicate that there is a higher
risk of PCV2 infection during fertilization
because spermatozoa may be associated with
PCV2 DNA.
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Differences in virulence and tropism of
PCV2 isolates have been suggested as a pos-
sible reason for PCV2-associated reproductive
failure when compared to PCV2-associated
diseases in growing swine [7, 24]. Two PCV2
isolates were used in this study and both orig-
inated from growing pigs with PCVAD. How-
ever, it is unknown whether these isolates were
also associated with reproductive failure in the
field.
In swine, the route of PCV2 exposure is
likely fecal-oral [46] and fetal infection has
been associated with viremia of the dam [34].
It was recently reported that reproductive
failure was associated with insemination
of PCV2 spiked semen in PCV2 positive
dams [39]. The dams were intranasally
inoculated 60 days prior to insemination, and
it was unknown whether dams were still
viremic at the time of insemination with
PCV2 spiked semen. The dams may have been
viremic which could have contributed to the
reproductive failure [39]. In support of this, in
a different study it has been shown that PCV2
experimentally inoculated gilts had detectable
PCV2 DNA in peripheral blood mononuclear
cells at 63 DPI [35].
The results of our study indicate that
PCV2 DNA present in semen ranging from
105.6 to 105.8 genomic copies/mL did not
cause reproductive failure, development of
dam associated anti-PCV2 antibodies, or fetal
infection. In addition, the semen extender used
in the study was found to have only a minimal
effect on the viability and infectivity of PCV2.
The amount of PCV2 present in semen is
likely determining whether PCV2 infection
occurs. Previously, non-extended raw semen
has been shown to infect PRRS negative
gilts [58], but extended semen, though causing
a reduction of pregnancy rates, did not
cause seroconversion or infection [53].
This indicates that the dose of viruses in
semen plays a major role in transmissibility.
In further support of this, only 20% of
negative gilts inseminated with PRRSV at
doses of 2 000 and 20 000 TCID50/50 mL
semen seroconverted while semen containing
PRRSV at  200 000 TCID50/50 mL semen
was infectious in 100% of the negative gilts3.
Alternatively, other possible explanations for
not having PCV2 infection in the gilts may
be related to the increased numbers of
inflammatory cells that are present in the
uterus associated with innate immunity during
proestrus, estrus, and early diestrus [5], age
related differences in susceptibility, or the
influence of altrenogest (Matrix®) on and
uterine defense mechanisms [10].
In summary, we determined that PCV2a
and PCV2b shed in semen were infectious in
a swine bioassay model. We also determined
that low doses of PCV2 (105.6–105.8 PCV2
genomic copies per mL) in extended semen
when used for artificial insemination does
not cause reproductive failure, seroconversion,
or PCV2 viremia in naïve gilts and their
offspring. The authors acknowledge that the
amount of PCV2 present in semen is a possible
contributing factor in transmissions of PCV2
via semen to swine herds that utilize artificial
insemination. We also are aware of potential
PCV2 isolate differences in association with
reproductive failure. Further investigations are
needed and currently under way.
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